Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengxing Li

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Nature Cell Biology|March 3, 2025
PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancerYizeng Fan, Yuzhao Wang, Weichao Dan, et al.
Clinical Neuroradiology|June 28, 2023
Treatment of Intracranial Vertebral Artery Dissecting Aneurysms Using Pipeline Embolization Devices : A Multicenter Cohort StudyYing Zhang, Fujunhui Zhang, Mirzat Turhon, et al.
Breast Cancer Research : BCR|December 28, 2019
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, et al.
Neurosurgery|September 21, 2022
In-Stent Stenosis After Pipeline Embolization Device in Intracranial Aneurysms: Incidence, Predictors, and Clinical OutcomesMirzat Turhon, Huibin Kang, Jian Liu, et al.
Clinical Chemistry and Laboratory Medicine|September 7, 2023
Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomicsFenfen Wang, Xinxing Li, Mengxing Li, et al.
Journal of Neurointerventional Surgery|March 31, 2022
Treatment of fusiform aneurysms with a pipeline embolization device: a multicenter cohort studyMirzat Turhon, Huibin Kang, Mengxing Li, et al.
Communications Biology|October 30, 2021
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancerMengxing Li, Suryavathi Viswanadhapalli, Bindu Santhamma, et al.
Molecular Cancer Therapeutics|May 31, 2019
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast CancerSuryavathi Viswanadhapalli, Yiliao Luo, Gangadhara R Sareddy, et al.
Nature Cancer|May 20, 2024
Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.
Nature Cancer|June 2, 2022
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Nature Cell Biology|March 3, 2025
PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancerYizeng Fan, Yuzhao Wang, Weichao Dan, et al.
Clinical Neuroradiology|June 28, 2023
Treatment of Intracranial Vertebral Artery Dissecting Aneurysms Using Pipeline Embolization Devices : A Multicenter Cohort StudyYing Zhang, Fujunhui Zhang, Mirzat Turhon, et al.
Breast Cancer Research : BCR|December 28, 2019
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, et al.
Neurosurgery|September 21, 2022
In-Stent Stenosis After Pipeline Embolization Device in Intracranial Aneurysms: Incidence, Predictors, and Clinical OutcomesMirzat Turhon, Huibin Kang, Jian Liu, et al.
Clinical Chemistry and Laboratory Medicine|September 7, 2023
Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomicsFenfen Wang, Xinxing Li, Mengxing Li, et al.
Journal of Neurointerventional Surgery|March 31, 2022
Treatment of fusiform aneurysms with a pipeline embolization device: a multicenter cohort studyMirzat Turhon, Huibin Kang, Mengxing Li, et al.
Communications Biology|October 30, 2021
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancerMengxing Li, Suryavathi Viswanadhapalli, Bindu Santhamma, et al.
Molecular Cancer Therapeutics|May 31, 2019
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast CancerSuryavathi Viswanadhapalli, Yiliao Luo, Gangadhara R Sareddy, et al.
Nature Cancer|May 20, 2024
Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.
Nature Cancer|June 2, 2022
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.
Pageof 8